Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab and Irinotecan in KRAS Wild-Type mCRC
NCT00792363Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Nov 2008
- Primary completion
- Dec 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in colorectal cancer (metastatic) (mCRC), sponsored by Vejle Hospital. Started Nov 2008; status: completed.
02
Drugs
panitumumab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00792363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792363.